Health Condition 1: G439- Migraine, unspecified
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Dr Hafeeza Sultana
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients who are above 18 years and below 50 years of age, patients who are mobile, and patients who are consenting to participate in the study. 2) Patients with denovo (newly diagnosed) with Migraine and presenting with headache.
Exclusion criteria
Exclusion criteria: 1)Patients who are below 18 years and above 50 years of age, patients who are mobile, and patients who are consenting to participate in the study. 2)Patients who have conditions or co-morbidities like Myocardial Infarction, cardiac failure, Resistant Hypertension, Chronic Kidney Disease, Acute Kidney Failure- On Hemodialysis, Sepsis, and Temporomandibular Joint disorders because these conditions increase serum CGRP levels. 3)Patients having conditions which mimic Migraine like Intracranial Aneurysms, Space Occupying Lesion, Pituitary Adenomas, Exertional Headache, Crash Migraine and Cerebral Venous Thrombosis. 4)Pregnant or postmenopausal women were not included in the study as research has suggested that these conditions effect serum CGRP levels.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome will be to measure serum CGRP levels in patients presenting with migraine and corelating it with symptom severity.Timepoint: One time point. Time 1 (T1): Patients serum CGRP levels are measured at baseline i.e., 0 weeks, and correlated with presenting symptoms. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Hafeeza Sultana
Owaisi Hospital and Research Centre
Outcome results
None listed